Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

EPOGEN- epoetin alfa solution

  1. Patient Information
  2. Inform Patients:
  3. Instruct Patients Who Self-administer Epogen Of The:
  4. Manufactured By:

Patient Information 

Sections or subsections omitted from the full prescribing information are not listed.

Inform Patients: 

  • Of the increased risks of mortality, serious cardiovascular reactions, thromboembolic reactions, stroke, and tumor progression[see Warnings and Precautions (5.1,5.2)].
  • To undergo regular blood pressure monitoring, adhere to prescribed anti-hypertensive regimen and follow recommended dietary restrictions.
  • To contact their healthcare provider for new-onset neurologic symptoms or change in seizure frequency.
  • Of the need to have regular laboratory tests for hemoglobin.
  • Risks are associated with benzyl alcohol in neonates, infants, pregnant women, and lactating women[see Use in Specific Populations (8.1,8.2,8.4)].

Instruct Patients Who Self-administer Epogen Of The: 

  • Importance of following the Instructions for Use.
  • Dangers of reusing needles, syringes, or unused portions of single-dose vials.
  • Proper disposal of used syringes, needles, and unused vials, and of the full container.

Epogen(epoetin alfa)

Manufactured By: 

Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 U.S.A.
U.S. License Number 1080

1989-2018 Amgen Inc. All rights reserved.

1xxxxxx- v33

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: